26 results
DEFA14A
AUPH
Aurinia Pharmaceuticals Inc
18 Apr 22
Additional proxy soliciting materials
7:36am
Acquisitions of preclinical compounds AUR200 and AUR300 bolster innovation pipeline Strong balance sheet to fund current initiatives and FDA-related post
DEF 14A
b3cpk6964towhvdb
10 May 21
Definitive proxy
4:06pm
PRE 14A
qzqslwu7yg rg
27 Apr 21
Preliminary proxy
4:32pm
8-K
EX-99.1
dqwo vk5vub1
24 Feb 21
Aurinia Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Operational Highlights
4:14pm
10-K
zni0 lzezvzcebbsrmm
24 Feb 21
Annual report
4:09pm
6-K
EX-99.1
j8e 9a59g3j8lp159
16 Dec 20
Aurinia Pharmaceuticals Inc. 6-K
12:00am
6-K
EX-99.1
ge1l9jy4 87k4iq
29 Oct 20
Aurinia Pharmaceuticals Inc. 6-K
9:00am
6-K
EX-99.3
j1hjxt2l
28 Apr 20
Notice of Annual General and Special Meeting of Shareholders
4:30pm
6-K
EX-99.1
0f0tqmewxy0
17 Mar 20
Aurinia Pharmaceuticals Inc. 6-K
5:05pm
40-F
EX-99.1
olhal1 fbef
5 Mar 20
Annual report (Canada)
4:06pm
6-K
EX-99.2
u3okmgb4fuh1s9y jy1
31 May 19
Notice of Annual General Meeting of Shareholders
8:26am
40-F
EX-99.1
fadcjikhtvgdjzs5lyd
19 Mar 19
Annual report (Canada)
4:16pm
6-K/A
EX-99.3
mbbklfupq2 nblcqdrq
17 May 18
Current report (foreign) (amended)
12:00am